{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:15:58Z","timestamp":1761884158244,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.reumae.2022.10.004","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:01:01Z","timestamp":1693551661000},"page":"351-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Description of a single centre cohort of patients with systemic sclerosis from the University Hospital of Buenos Aires and factors associated with lung function deterioration. A retrospective study"],"prefix":"10.1016","volume":"19","author":[{"given":"Juan I.","family":"Enghelmayer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"L\u00f3pez Meiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ail\u00edn","family":"Vallejos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Felder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Milena","family":"Pertuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cora G.","family":"Legarreta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasti\u00e1n","family":"Leiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Dubinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2022.10.004_bib0005","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reumae.2022.10.004_bib0010","first-page":"1017","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: A systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatol (United Kingdom)."},{"key":"10.1016\/j.reumae.2022.10.004_bib0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1183\/16000617.00002915","article-title":"Interstitial lung disease in systemic sclerosis: Where do we stand?","volume":"24","author":"Cappelli","year":"2015","journal-title":"Eur Respir Rev."},{"key":"10.1016\/j.reumae.2022.10.004_bib0020","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.reumae.2022.10.004_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: A longitudinal EUSTAR study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.reumae.2022.10.004_bib0030","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.reumae.2022.10.004_bib0035","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1513\/AnnalsATS.201806-362OC","article-title":"Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression","volume":"15","author":"Guler","year":"2018","journal-title":"Ann Am Thorac Soc."},{"key":"10.1016\/j.reumae.2022.10.004_bib0040","doi-asserted-by":"crossref","first-page":"170102","DOI":"10.1183\/16000617.0102-2017","article-title":"Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease","volume":"27","author":"Caron","year":"2018","journal-title":"Eur Respir Rev."},{"key":"10.1016\/j.reumae.2022.10.004_bib0045","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"\u201cERS\/ATS Task Force on Undifferentiated Forms of CTD-ILD\u201d. An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J."},{"key":"10.1016\/j.reumae.2022.10.004_bib0050","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"INBUILD Trial Investigators. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.reumae.2022.10.004_bib0055","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for Systemic Sclerosis\u2013Associated Interstitial Lung Disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.reumae.2022.10.004_bib0060","doi-asserted-by":"crossref","unstructured":"Bernstein EJ, Huggins JT, Hummers LK, Owens GM. Systemic Sclerosis With Associated Interstitial Lung Disease: Management Considerations and Future Directions. Am J Manag Care. 2021; 27(suppl 7):S138S146.","DOI":"10.37765\/ajmc.2021.88656"},{"key":"10.1016\/j.reumae.2022.10.004_bib0065","first-page":"52","article-title":"Autoimmune interstitial lung disease in Latin America. EPIMAR Group","volume":"199","author":"Vivero","year":"2019","journal-title":"EPIMAR Multicenter Cohort Study. Clin Immunol."},{"key":"10.1016\/j.reumae.2022.10.004_bib0070","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3899\/jrheum.111582","article-title":"Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients","volume":"39","author":"Sampaio-Barros","year":"2012","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reumae.2022.10.004_bib0075","doi-asserted-by":"crossref","unstructured":"Scolnik M, Lancioni E, Saucedo C, Marin J, Sabelli M, Bedran Z, et al. Systemic sclerosis in Argentina: evaluation of a large cohort from a single centre and comparison with other international series. Clin Exp Rheumatol. 2014; 32(Suppl. 86):S94-7.","DOI":"10.1155\/2014\/716358"},{"key":"10.1016\/j.reumae.2022.10.004_bib0080","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial Lung Disease in Systemic Sclerosis A Simple Staging System","volume":"177","author":"Goh","year":"2008","journal-title":"Amer J Resp Crit Care Med."},{"key":"10.1016\/j.reumae.2022.10.004_bib0085","first-page":"504","article-title":"Evoluci\u00f3n de la funci\u00f3n pulmonar en la enfermedad intersticial pulmonar asociada a esclerodermia tratada con ciclofosfamida: An\u00e1lisis retrospectivo de una serie de casos en un hospital universitario","volume":"14","author":"Enghelmayer","year":"2014","journal-title":"RAMR."},{"key":"10.1016\/j.reumae.2022.10.004_bib0090","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: An american college of rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reumae.2022.10.004_bib0095","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reumae.2022.10.004_bib0100","first-page":"11","volume":"2","author":"Khanna","year":"2017","journal-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis on behalf of the Scleroderma Clinical Trials Consortium and the World Scleroderma Foundation J Scleroderma Relat Disord."},{"key":"10.1016\/j.reumae.2022.10.004_bib0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/2397198319826467","volume":"4","author":"Herrick","year":"2019","journal-title":"Raynaud's Phenomenon. J Scleroderma Relat Disord"},{"key":"10.1016\/j.reumae.2022.10.004_bib0110","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201710-1981ST","article-title":"Recommendations for a standardized pulmonary function report. An official American Thoracic Society technical statement","volume":"196","author":"Culver","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.reumae.2022.10.004_bib0115","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"RELIEF investigators. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.reumae.2022.10.004_bib0120","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reumae.2022.10.004_bib0125","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3125","article-title":"GENISOS Study GroupPredictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort","volume":"12","author":"Assassi","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.reumae.2022.10.004_bib0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis-associated lung disease","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.reumae.2022.10.004_bib0135","doi-asserted-by":"crossref","first-page":"e0181692","DOI":"10.1371\/journal.pone.0181692","article-title":"Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease","volume":"12","author":"Le Gouellec","year":"2017","journal-title":"PLoS ONE."},{"key":"10.1016\/j.reumae.2022.10.004_bib0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","article-title":"Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database","volume":"80","author":"Hoffmann-Vold","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reumae.2022.10.004_bib0145","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.40557","article-title":"Smoking in systemic sclerosis longitudinal European Scleroderma Trials and Research group study","volume":"70","author":"Jaeger","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.reumae.2022.10.004_bib0150","doi-asserted-by":"crossref","first-page":"1802182","DOI":"10.1183\/13993003.02182-2018","article-title":"Pulmonary physiology is poorly associated with radiological extent of disease in systemic sclerosis-associated interstitial lung disease","volume":"53","author":"Jhajj","year":"2019","journal-title":"Eur Respir J."}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574323000680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574323000680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:03:07Z","timestamp":1761879787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574323000680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2173574323000680"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2022.10.004","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Description of a single centre cohort of patients with systemic sclerosis from the University Hospital of Buenos Aires and factors associated with lung function deterioration. A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2022.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2022.10.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}